NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
    4.
    发明申请
    NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME 有权
    新颖的细菌和包含其的抗菌组合物

    公开(公告)号:US20160076003A1

    公开(公告)日:2016-03-17

    申请号:US14767266

    申请日:2014-02-26

    Abstract: Provided is a novel bacteriophage ΦCJ22 (KCCM11364P). In addition, provided is an antibacterial composition containing the bacteriophage ΦCJ22 (KCCM11364P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases caused by Clostridium perfringens in animals except for humans by using the bacteriophage ΦCJ22 (KCCM11364P) or an antibacterial composition containing the bacteriophage ΦCJ22 (KCCM11364P) as an active ingredient.

    Abstract translation: 提供了一种新型噬菌体ΦCJ22(KCCM11364P)。 此外,提供含有噬菌体ΦCJ22(KCCM11364P)作为活性成分的抗菌组合物。 此外,提供了通过使用噬菌体ΦCJ22(KCCM11364P)或含有噬菌体ΦCJ22(KCCM11364P)的抗菌组合物作为活性成分的预防和/或治疗由产气荚膜梭菌引起的感染性疾病的方法。

    NOVEL BACTERIOPHAGE AND COMPOSITION COMPRISING SAME
    6.
    发明申请
    NOVEL BACTERIOPHAGE AND COMPOSITION COMPRISING SAME 审中-公开
    新颖的微生物和包含它们的组合物

    公开(公告)号:US20170037380A1

    公开(公告)日:2017-02-09

    申请号:US15303504

    申请日:2015-03-13

    Abstract: The present invention relates to a novel bacteriophage ΦCJ28 (KCCM11466P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of animals excluding humans by using the composition.

    Abstract translation: 本发明涉及新型噬菌体ΦCJ28(KCCM11466P)和含有该活性成分的组合物。 此外,本发明涉及通过使用该组合物来预防和/或治疗由肠毒素性大肠杆菌(ETEC)引起的感染性疾病的方法,所述感染性疾病由人类除外。

Patent Agency Ranking